(Total Views: 111)
Posted On: 04/13/2023 11:55:51 AM
Post# of 74546

$ATAI News Article - atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) https://marketwirenews.com/news-releases/atai...82905.html


My Twitter: WhyteStocks
Scroll down for more posts ▼